Neal Statement on President Trump’s Prescription Drug Proposal

May 11, 2018
Press Release

WASHINGTON, DC – Ways and Means Committee Ranking Member Richard Neal (D-MA) today released the following statement after the release of President Trump’s prescription drug pricing proposal:
“For many years, the issue of prescription drug pricing has been a major cause of concern for myself, my Democratic colleagues on the Ways & Means Committee and the larger Democratic Caucus. We have all heard from constituents who are struggling to afford prescription drug prices while bad actors, like Martin Shkreli and others, prey on desperate patients with unnecessary price hikes. It is encouraging to see the President of the United States use the power of his office to begin a national dialogue on this issue, but far more must be done than what President Trump outlined today. Today’s proposal stops short of providing meaningful solutions that will solve this problem and will not prevent the types of abuses caused by bad actors. I am also disappointed that the president has abandoned a signature campaign promise to demand lower prices through a Medicare expenditure. Democrats on the Ways & Means Committee will continue to look for real solutions that will restrain drug prices for seniors and families, without killing important innovation, including using the power of the federal government to bring down prices for seniors across the country.”